ChemoFX logo and an image of a mother and her child
Her cancer is being treated with 10 different chemotherapies.
But she isn't.
By testing for relevant targets within a patient's tumor before treating a cancer patient, BioSpeciFx® can be used in combination with ChemoFx® to help determine the chemotherapies that are more likely to be effective and guide physicians away from therapies that are more likely to be ineffective - giving patients a powerful advantage in the fight against cancer.

What is BioSpeciFx?
BioSpeciFx® is a select group of clinically relevant and validated biomarker tests associated with drug response and patient prognosis. BioSpeciFx® testing is available for all solid tumor types. In gynecologic cancers, BioSpeciFx® can be used in combination with ChemoFx®, to create a Comprehensive Tumor Profile, which may allow physicians to more completely define their patient's cancer.
Learn more by going to ChemoFX.com